FDA Clearance Tracker · K211338
EMBOTRAP III Revascularization Device
Last checked: Nov 19, 2026Latest source record: Jul 30, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Jul 30, 2021
Substantially Equivalent
Time to decision
88 days
Received May 3, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K211338
- Device name
- EMBOTRAP III Revascularization Device
- Applicant
- Neuravi, Ltd.
- Applicant location
- Galway, IE
- Received
- May 3, 2021
- Decided
- Jul 30, 2021
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Catheter, Thrombus Retriever (NRY)
- Device class
- Class II
- Regulation
- 21 CFR 870.1250
- Specialty
- Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NRY. The earliest in FDA's data is K033736, decided Aug 11, 2004.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K211338
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Neuravi, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K212908 · Decided Oct 13, 2021 · 30 days after receipt
Device type: Catheter, Thrombus Retriever (NRY) · Cardiology
K193063 · Decided Jul 14, 2020 · 253 days after receipt
Device type: Catheter, Thrombus Retriever (NRY) · Cardiology
K173452 · Decided May 9, 2018 · 184 days after receipt
Device type: Catheter, Thrombus Retriever (NRY) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.